USE OF NEUTROPHIL ELASTASE INHIBITORS IN LIVER DISEASE

The invention relates to methods for treating chronic liver disease, in particular nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH), with neutrophil elastase inhibitors. The invention further relates to pharmaceutical compositions comprising neutrophil elastase inhibi...

Full description

Saved in:
Bibliographic Details
Main Authors SATYAL SANJEEV, SAVAGE SCOTT, B. ROBERTS, HUH HOYOUNG, WANG XUEYAN
Format Patent
LanguageChinese
English
Published 05.11.2021
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

Abstract The invention relates to methods for treating chronic liver disease, in particular nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH), with neutrophil elastase inhibitors. The invention further relates to pharmaceutical compositions comprising neutrophil elastase inhibitors. 本发明涉及使用中性粒细胞弹性蛋白酶抑制剂治疗慢性肝病、特别是非酒精性脂肪肝病(NAFLD)和非酒精性脂肪性肝炎(NASH)的方法。本发明还涉及包含中性粒细胞弹性蛋白酶抑制剂的药物组合物。
AbstractList The invention relates to methods for treating chronic liver disease, in particular nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH), with neutrophil elastase inhibitors. The invention further relates to pharmaceutical compositions comprising neutrophil elastase inhibitors. 本发明涉及使用中性粒细胞弹性蛋白酶抑制剂治疗慢性肝病、特别是非酒精性脂肪肝病(NAFLD)和非酒精性脂肪性肝炎(NASH)的方法。本发明还涉及包含中性粒细胞弹性蛋白酶抑制剂的药物组合物。
Author SAVAGE SCOTT
WANG XUEYAN
HUH HOYOUNG
SATYAL SANJEEV
B. ROBERTS
Author_xml – fullname: SATYAL SANJEEV
– fullname: SAVAGE SCOTT
– fullname: B. ROBERTS
– fullname: HUH HOYOUNG
– fullname: WANG XUEYAN
BookMark eNrjYmDJy89L5WQwCw12VfB3U_BzDQ0J8g_w8PRRcPVxDA5xBAp7-nl4OnmG-AcFA5kKPp5hrkEKLp7BrkA5HgbWtMSc4lReKM3NoOjmGuLsoZtakB-fWlyQmJyal1oS7-xnaGhsZmhiYG7gaEyMGgAWvymZ
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate 中性粒细胞弹性蛋白酶抑制剂在肝病中的用途
ExternalDocumentID CN113614070A
GroupedDBID EVB
ID FETCH-epo_espacenet_CN113614070A3
IEDL.DBID EVB
IngestDate Fri Jul 19 15:06:59 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Chinese
English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CN113614070A3
Notes Application Number: CN201980040583
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20211105&DB=EPODOC&CC=CN&NR=113614070A
ParticipantIDs epo_espacenet_CN113614070A
PublicationCentury 2000
PublicationDate 20211105
PublicationDateYYYYMMDD 2021-11-05
PublicationDate_xml – month: 11
  year: 2021
  text: 20211105
  day: 05
PublicationDecade 2020
PublicationYear 2021
RelatedCompanies PH PHARMA CO., LTD
RelatedCompanies_xml – name: PH PHARMA CO., LTD
Score 3.4932592
Snippet The invention relates to methods for treating chronic liver disease, in particular nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Title USE OF NEUTROPHIL ELASTASE INHIBITORS IN LIVER DISEASE
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20211105&DB=EPODOC&locale=&CC=CN&NR=113614070A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dS8NALMwp6ptORecHFaRvRcfaXvtQZLteaaW2pe3G3kava1EftuEqgr_e3LE5X_QtJHCXC5dLcndJAO6smWge26810i8qTcc9pdkFKTXL7hVmSWqLF_KXb2T6I_1pYkxa8LbJhZF1Qj9lcUTUqBL1vZHn9XJ7ieXKv5Wre_6KqMWjlzuuuo6OMZrBqVV36LAkdmOqUurQSI1SR7QuwViCPAx2YFe40aLOPhsPRVbK8rdJ8Y5gL8HR5s0xtL5eOnBAN53XOrD_vH7wRnCte6sTMEcZU2JPidgoT-PED0KFhYMsHyA6iPxgGORxmiGohMGYpYobZAxpp3DrsZz6GjIw_VntlEZbXvtn0J4v5tU5KFbdK7le8Ep4MFVtcsJnZlkRG02QTXrGBXT_Hqf7H_ESDoXkZIKdcQXt5v2jukZL2_AbKaJvbqp8oA
link.rule.ids 230,309,786,891,25594,76903
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8gGvFNUaP4NROzt0UJsI6HxUDXZdXRkW0Q3sg6tqgPQGTGxL_eWwPii7411-Tau_R6_bW9O4A7a1YWj23lBmklmdHGNWV0E5IaVreZmCnJLZmoX77C9Ebtp0lnUoG3TSyMyhP6qZIjokWlaO-F2q-X20ssR_2tXN3LVyQtHt3YdvQ1OkY0g0PrTt9mw8AJqE6pTYUuQrssXYJYgjz0dmCXICRUUGncL6NSlr9dinsIe0PkNi-OoPL1Uoca3VReq8P-YP3gjc217a2OwRxFTAtcTbBRHAZDj_sa83tR3EMyFx7v8zgII2xqPh-zUHN4xLDvBG5dFlPPwAlMf6SdUrGda-sUqvPFPDsDzcqbqWwnMitPMFluSiJnZpoRlMTskmbnHBp_82n813kDNS8e-FOfi-cLOCi1qILtOpdQLd4_siv0uoW8Vur6BmeQf4o
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=USE+OF+NEUTROPHIL+ELASTASE+INHIBITORS+IN+LIVER+DISEASE&rft.inventor=SATYAL+SANJEEV&rft.inventor=SAVAGE+SCOTT&rft.inventor=B.+ROBERTS&rft.inventor=HUH+HOYOUNG&rft.inventor=WANG+XUEYAN&rft.date=2021-11-05&rft.externalDBID=A&rft.externalDocID=CN113614070A